article thumbnail

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Digital Health Global

The study, led by principal investigator Nitin Ohri, M.D., The study, led by principal investigator Nitin Ohri, M.D., This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., Chief Medical Officer, Koneksa. “By

article thumbnail

Infographic: Digital Measures in Oncology Drug Development

ActiGraph

Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Infographic: Digital Measures in Oncology Drug Development

ActiGraph

Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.

article thumbnail

Medable Partners with Duke BASE Lab to Study Patient Preference of Electronic Informed Consent in Clinical Trials

Digital Health Global

New study* reveals greater comprehension and personal engagement with enhanced e-consent PALO ALTO, Calif.–(BUSINESS The study population was diverse in gender, age, race, and geographic location. The enhanced eIC] is more appealing to me as a human being, not just a study subject,” said a 63-year-old male participant. “It

article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

This expansion mirrors a trend identified in an industry report jointly published by Biofourmis and HealthXL last year, predicting widespread adoption of digital endpoints by pharmaceutical companies in drug development programs by 2030.

article thumbnail

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drug development, but is often characterised by inefficiencies and delays.

article thumbnail

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Digital Health Global

The LEARNS study will investigate the Koneksa neuroscience solution, as well as the Beacon Biosignals platform, applied to at-home EEG, compared with in-clinic polysomnography, in neurological and sleep disorders. The study will also evaluate whether assessment combinations can identify diagnostic features at the cohort diagnostic boundary.